15 results
8-K
EX-10.1
ELVN
Enliven Therapeutics Inc
19 Mar 24
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
8:46am
dispute with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor
8-K
EX-1.1
ELVN
Enliven Therapeutics Inc
23 Jun 23
Entry into a Material Definitive Agreement
6:18pm
with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company
S-4/A
dw015w5
19 Dec 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
afa66cg
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
425
2db12cg gu
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-2.1
0nx3e4 shmznlo
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
DEF 14A
d7yppzau
18 May 21
Definitive proxy
4:06pm
S-1
EX-10.13
kqka8ypsd6gg1o
14 Feb 20
IPO registration
5:05pm
DRS
EX-10.13
0z1vtpg ytw
15 Aug 19
Draft registration statement
12:00am
- Prev
- 1
- Next